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Abstract
Purpose—To investigate whether preterm birth (PTB) is associated with greater cardiovascular 
disease (CVD) risk in a longitudinal cohort.
Methods—We examined differences in SBP, DBP, insulin resistance (HOMA-IR), total 
cholesterol, HDL, LDL, triglycerides, CRP, and IL-6 at 3 years postpartum between women who 
delivered preterm (gestation<37 weeks; n=54) vs. term (≥37 weeks; n=751) using multivariable 
linear regression. We also assessed relations with BMI, weight change from pre-pregnancy, and 
waist circumference at 3 and 7 years postpartum.
Results—Median age at enrollment was 33.9 years (range: 16.4–44.9). After adjusting for age, 
race, pre-pregnancy BMI, parity, marital status, education, and SBP during early pregnancy, 
women with PTB had 3.99 (95% CI: 0.82, 7.16) mmHg higher SBP and 7.01 (1.54, 12.50) mg/dL 
lower HDL than those who delivered at term. The association with SBP was attenuated after 
accounting for hypertension before or during pregnancy (2.78 [−0.30, 5.87] mmHg). PTB was not 
related to other postpartum outcomes.
Conclusions—PTB is related to greater CVD risk by 3 years postpartum, as indicated by higher 
SBP and lower HDL. While these associations may be due to preexisting conditions exacerbated 
during pregnancy, PTB may flag high-risk women for more vigilant CVD monitoring and lifestyle 
interventions.
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INTRODUCTION
Preterm birth, defined as gestation length <37 weeks, occurs in approximately 12.5% of 
births in the U.S. each year, affecting roughly 1 in 8 infants (1). Women with a history of 
preterm delivery are at two- to three-fold greater risk of cardiovascular disease (CVD) (2–7). 
Yet, the mechanistic pathways are not well understood since most studies investigating this 
relation have been retrospective analyses of large population registries (3, 4, 6) or 
hospitalization records (2, 5, 6), precluding the ability to explore associations with 
biomarkers of disease progression.
Although the relations of other pregnancy complications, such as preeclampsia (5, 8–12) and 
gestational diabetes (10, 11, 13–15), with postpartum cardiometabolic traits are well-studied, 
we are aware of only two published papers that examined subclinical markers of CVD with 
respect to preterm birth. In an investigation of mothers in the Avon Longitudinal Study of 
Parents and Children (ALSPAC), Fraser et al. (10) reported that women who delivered 
preterm had higher blood pressure 18 years after delivery, but were not different from their 
counterparts in terms of glycemia, lipids, or adiposity. Additionally, the association with 
blood pressure was largely explained by hypertension during pregnancy (10). However, in 
another study of non-hypertensive non-preeclamptic mothers in the Women and Infants 
Study of Healthy Hearts (WISH) cohort, Catov et al. (16) found that preterm delivery 
predicted higher blood pressure and an atherogenic lipid profile in the decade following 
pregnancy. The limited literature points towards the need for additional studies to explore 
possible etiological mechanisms linking preterm birth to later maternal cardiovascular risk. 
A better understanding of the biological processes could unveil intervention opportunities 
and lead to improvements in preventive strategies for both conditions.
In this study, we examined the relation of preterm birth with long-term maternal 
cardiovascular traits, including blood pressure, glycemia, lipids, and inflammation 3 years 
after delivery, as well as indicators of overall and central adiposity at 3 and 7 years 
postpartum in a longitudinal cohort of reproductive-aged women in the Boston area.
METHODS
Study population
This study included participants of Project Viva, an ongoing pre-birth cohort of pregnant 
women and their children enrolled between 1999 and 2002 at a multispecialty clinic in 
eastern Massachusetts. Details on recruitment and exclusion criteria are reported elsewhere 
(17). All women provided written informed consent and the Harvard Pilgrim Health Care 
Institutional Review Board approved this study.
Perng et al. Page 2













Since the aim of this investigation was to examine the relation of preterm birth with 
maternal health at 3 and 7 years postpartum, only participants who did not have an 
intervening pregnancy between the index birth and the times of outcome assessment were 
eligible. Of the 2128 mothers who delivered a live singleton, 1534 did not have an 
intervening pregnancy by the 3-year visit. We further excluded 769 women without data on 
any of the 3-year outcomes, and 23 participants missing information on key adjustment 
covariates (marital status and education), yielding a final analytic sample of 746 women. Of 
these women, 567 (76%) provided a blood specimen; 179 were collected in the fasting state 
(we did not require that women come to the visit fasting). For the 7-year outcomes, there 
were 1492 women without an intervening pregnancy, 548 of whom we had data on weight 
or waist circumference at the 7-year assessment. After excluding 18 women with incomplete 
covariate information, the final sample for the 7-year postpartum analysis comprised 530 
mothers; we did not collect blood at 7 years. The 805 women in either the 3- or 7-year 
postpartum analysis were distinct but overlapping (n=471 in both; n=59 in 3-year sample 
only; n=275 in the 7-year sample only), and were similar to those not included (n=1323) in 
terms of race, ethnicity, marital status, household income, education level, or smoking habits 
during pregnancy. However, as expected, the women in this study, none of whom had a 
pregnancy after the index pregnancy, were older (mean age at enrollment 33.2 vs. 31.0 
years) and had a higher frequency of multiparity (69.8% vs. 41.5%). The study participants 
also had higher pre-pregnancy body mass index (BMI; 25.3 vs. 24.7 kg/m2), and accordingly 
gained less total weight during pregnancy (15.0 vs. 15.8 kg) than those not included.
Exposure: preterm birth
We calculated gestational age in weeks by subtracting the date of the last menstrual period 
from the date of delivery. For subjects whose ultrasound pregnancy dating estimate differed 
by more than 10 days from the last menstrual period, we used the dating obtained from the 
2nd trimester ultrasound to determine gestational age at birth. We categorized infants as 
preterm if the gestational age at birth was less than 37 completed weeks of gestation.
Outcomes
Anthropometric assessment—At the in-person 3- and 7-year postpartum visits, 
research assistants measured the women’s weight to the nearest 0.1 kg using a research-
grade electronic scale, height to the nearest 0.1 cm, and waist circumference to the nearest 
0.1 cm using a Lefkin woven tape. Change in weight was calculated as the difference 
between weight at 3 or 7 years postpartum and self-reported pre-pregnancy weight. 
Postpartum BMI was calculated using weight and height (weight [kg]/ (height [m])2).
Laboratory procedures for cardiometabolic biomarkers—At the 3-year visit, 
trained phlebotomists collected a blood specimen, which was processed within 24 hours and 
stored at −80°C until time of analysis. We assayed glucose, fasting insulin, total cholesterol, 
high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides from the 
fasting blood samples only (n = 179). Glucose was measured enzymatically on a Hitachi 911 
analyzer using Roche Diagnostic reagents. Fasting insulin was measured with a micro-
particle enzyme immunoassay on an IMZ analyzer (Abbott Laboratories). We used these 
values to determine insulin resistance using the homeostatic model: HOMA-IR= (fasting 
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insulin [μU/mL]×fasting glucose [mmol/L]/22.5). Total cholesterol was measured 
enzymatically; LDL was quantified with a homogenous direct method from Genzyme Corp; 
HDL was assessed using a direct enzymatic colorimetric assay, and triglycerides were 
determined enzymatically with correction for endogenous glycerol.
Inflammation biomarkers, C-reactive protein (CRP) and interleukin-6 (IL-6), were assayed 
from all blood specimens (n=567). We used an immunoturbidimetric high-sensitivity assay 
on a Hitachi 911 analyzer (Roche Diagnostics) with Denka Seiken reagents and calibrators 
to quantify CRP concentrations. Plasma IL-6 was measured by ultrasensitive ELISA.
We measured systolic and diastolic blood pressure (SBP and DBP) 5 times, each 1 minute 
apart, using a Dinamap (Critikon, Inc.) Pro 100 automated oscillometric recorder.
Covariates
At enrollment, women completed surveys inquiring on sociodemographic information 
including race/ethnicity (Black/Hispanic/White/Asian/other), education level (primary/
secondary/university) parity (continuous), and partner’s height (cm) and weight (kg); and 
lifestyle characteristics including smoking habits (current/former/never), diet (evaluated as a 
continuous score representing adherence to various dietary patterns), and physical activity 
(hours per week). In postpartum questionnaires, mothers provided updates on lifestyle and 
sociodemographic characteristics and reported on duration of breastfeeding.
We calculated pre-pregnancy BMI (kg/m2) using self-reported pre-pregnancy weight and 
height. We derived first trimester SBP as the first blood pressure measurement documented 
in prenatal medical records. The medical records also provided information on perinatal 
characteristics including prenatal glucose tolerance status (normoglycemic/isolated 
hyperglycemina/impaired glucose tolerance/gestational diabetes) (18), offspring sex (male/
female), and birthweight (g). We determined birthweight-for-gestational age and sex z-
scores (‘fetal growth’) using national reference data (19). Small for gestational age and sex 
(SGA) was defined as less than 10th percentile and large for gestational age and sex (LGA) 
as greater than 90th percentile.
To identify women with hypertensive disorders of pregnancy, we reviewed outpatient charts 
for blood pressure and urine protein results, and created a 4-level variable with the 
categories normotensive, chronic hypertension, gestational hypertension, and preeclampsia. 
We categorized women as having chronic hypertension if they were taking antihypertensive 
medications or if they had two elevated clinically-measured blood pressure values 
(systolic>140 mmHg or diastolic>90 mmHg) before 20 weeks gestation. We categorized a 
woman as having gestational hypertension if she did not have chronic hypertension but 
developed elevated systolic (>140 mmHg) or diastolic (>90 mmHg) blood pressure on two 
or more occasions after 20 weeks gestation. We classified women as having preeclampsia if 
they did not have chronic hypertension but developed increased blood pressure as just 
defined in addition to proteinuria (dipstick value of 1+ on two or more occasions or ≥2 once) 
>4 hours but ≤7 days or less apart, or if they had chronic hypertension and developed 
proteinuria after 20 weeks gestation.
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To identify potential confounders to the relation of preterm birth with the maternal 
outcomes, we examined the distribution of preterm birth prevalence across categories of 
sociodemographic, lifestyle, and peripartum characteristics. We evaluated the statistical 
significance of the associations with the Wald chi-squared statistic for categorical variables, 
and a test of linear trend for ordinal variables.
Next, we estimated mean differences and 95% confidence intervals (CI) for maternal 
cardiovascular risk markers (SBP, DBP, total cholesterol, HDL, LDL, triglycerides, HOMA-
IR, CRP, and IL-6) at 3 years postpartum for women who had a preterm birth vs. those who 
delivered at term. For blood pressure, we focused on results for SBP since it is a better 
predictor of long term outcomes (20) and is more accurately measured than DBP (21). 
Biomarkers that were not normally distributed (triglycerides, HOMA-IR, CRP, and IL-6) 
were natural log-(ln)-transformed prior to use in the regression models. In multivariable 
analyses, we constructed a series of models that first accounted for non-modifiable 
characteristics (Model 1: maternal age and race/ethnicity), followed by sociodemographic 
and perinatal factors (Model 2: Model 1 + pre-pregnancy BMI, parity, marital status and 
education level), followed by hypertensive disorders of pregnancy (Model 3), which were 
previously reported to predict postpartum cardiometabolic health (10). Model 2 for blood 
pressure also included the first clinically-measured SBP during the first trimester, and Model 
3 for HOMA-IR also included gestational glucose tolerance, in 4 categories. We used the 
same set of models to examine associations with the maternal adiposity indicators (BMI, 
weight change from pre-pregnancy weight, and waist circumference) at 3 and 7 years 
postpartum. The adjustment covariates were selected based on bivariate associations and our 
a priori knowledge of CVD risk factors. We also examined associations after accounting for 
lifestyle characteristics (diet, physical activity, and smoking habits at the postpartum time 
points) that could influence the maternal outcomes, which resulted in no material difference 
in the estimates, so these variables were not included in final models.
Excluding 4 mothers who had a planned preterm birth (based on indication of planned 
Cesarean section [‘C-section’], as opposed to an unplanned C-section or vaginal birth) 
yielded no difference in the results. We also examined the associations with SBP after 
excluding women with chronic hypertension and those with a pre-pregnancy hypertensive 
history and observed no substantial differences in the direction, magnitude, or precision of 
the associations, thus we included all women in the analysis and report these estimates 
separately in text.
In sensitivity analyses, we further accounted for maternal lifestyle characteristics at each of 
the postpartum time points, including smoking status, physical activity, and diet. The results 
were essentially unchanged after inclusion of these variables, so they were not included in 
the final models.
All analyses were performed with SAS software (v9.3; SAS Institute Inc., Cary, NC).
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Median age at enrollment was 33.9 years (range: 16.4–44.9); 65.1% of women were white. 
Mean±SD pre-pregnancy BMI was 25.3±5.6 kg/m2. The overall prevalence of preterm birth 
was 6.7% (n=54). In bivariate analysis (Table 1), the frequency of preterm birth differed by 
race/ethnicity, with the highest prevalence in Asian women, and the lowest in White women. 
As expected, preterm birth occurrence was higher among women with preeclampsia and 
chronic hypertension, as well as in single mothers, women with lower education, and those 
who delivered a small-for-gestational age infant.
The associations of preterm birth with maternal cardiometabolic traits at 3 years postpartum 
are presented in Table 2. In our basic model that accounted for age and race/ethnicity 
(Model 1), women who delivered preterm had 4.93 (95% CI: 1.51, 8.35) mmHg higher SBP 
and 7.58 (1.95, 13.21) mg/dL lower HDL than their counterparts. Preterm birth also 
corresponded with 0.37 (0.04, 0.70) units higher ln-transformed HOMA-IR, which translates 
to 45% (4%, 101%) higher HOMA-IR after back-transformation via exponentiation. In 
Model 2, accounting for pre-pregnancy BMI, parity, marital status, and education somewhat 
attenuated the association with SBP (3.81 [0.58, 7.04] mmHg) and HDL (−7.01 [−12.50, 
−1.54] mg/dL), whereas the estimate for HOMA-IR diminished to 2/3 its previous 
magnitude with the 95% CI spanning the null (0.25 [−0.05, 0.56] units ln-transformed 
HOMA-IR). Adjustment for first trimester SBP and gestation length at the time of 
assessment did not attenuate the association between preterm birth and SBP (3.99 [0.82, 
7.16] mmHg; Table 2 Model 2). Accounting for hypertensive disorders of pregnancy (Model 
3) attenuated the estimate for SBP by approximately 30% to 2.78 (−0.30, 5.87) mmHg, 
while the estimate for HDL was only slightly attenuated (−6.67 [−12.13, −1.20] mg/dL). For 
HOMA-IR, adjusting for hypertensive disorders and gestational glucose tolerance 
individually attenuated the estimate by about 4% for each; accounting for both conditions in 
Model 3 led to further attenuation to approximately 3/4 the previous magnitude (0.20 
[−0.12, 0.51] units ln-transformed HOMA-IR). Trends for DBP were similar to those for 
SBP, but were weaker with wider confidence intervals (Table 2). Preterm birth was not 
associated with other biomarkers.
Because the relation of preterm birth with postpartum SBP could be explained by 
preexisting hypertension, we also examined the association after excluding women who 
reported pre-pregnancy of hypertension or were classified as having chronic hypertension 
(n=13 both conditions, n=1 chronic hypertension only, n=15 hypertensive history only). 
Although the estimates were smaller in magnitude than in the full analysis (Model 1: 4.18 
[0.76, 7.60] mmHg; Model 2: 3.27 [0.09, 6.44] mmHg; Model 3: 3.20 [0.13, 6.27] mmHg), 
the overall trend recapitulated the main results and the 95% CIs all excluded the null.
Preterm birth was not related to any of the postpartum anthropometric outcomes at either 3 
years (Table 2) or 7 years (data not shown).
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Epidemiologic evidence has associated preterm birth with future maternal CVD morbidity 
and mortality, but few studies have been able to examine potential mechanisms linking these 
conditions. Using detailed obstetric records and research-quality measures of anthropometry 
and cardiometabolic traits at 3 and 7 years postpartum in a longitudinal cohort of U.S. 
women, we found that mothers who delivered a preterm infant had higher SBP (and to a 
lesser degree, higher DBP) and lower HDL cholesterol by 3 years postpartum, a pattern 
associated with greater cardiometabolic risk. These relations were robust to adjustment for 
sociodemographic, perinatal, and lifestyle characteristics, as well as blood pressure during 
the first trimester.
Researchers have speculated that because premature parturition and CVD share common 
antecedents, such as inflammation, dyslipidemia, and endothelial dysfunction, its occurrence 
could unmask later cardiovascular risk (2, 22). This hypothesis aligns with a more 
established literature on preeclampsia, which suggests that placental insufficiency and 
hypertensive disorders manifest among women who were already at higher risk prior to 
pregnancy (23). Less is known of these relations with regards to preterm birth, and only two 
comparable studies have assessed possible mechanistic pathways. Using data from 3,416 
ALSPAC mothers, Fraser et al. (10) examined the associations of adverse pregnancy 
outcomes with a range of cardiovascular risk factors, and found that preterm birth 
corresponded with higher SBP 18 years after delivery. However, adjusting for hypertensive 
disorders of pregnancy attenuated the association (10), suggesting that the relation transpired 
from the influence of hypertension during pregnancy on occurrence of preterm birth, and the 
subsequent correlation between pregnancy and postpartum blood pressure. In another study 
of 487 women in the WISH cohort, Catov et al. (16) sought to isolate the ‘effect’ of preterm 
birth on postpartum health from that of hypertensive diseases by restricting the study sample 
to non-preeclamptic women without a history of hypertension. Women with a preterm birth 
had higher blood pressure, as well as higher total cholesterol, LDL, and triglycerides, 4 to 12 
years after pregnancy. The authors also noted that the magnitude of associations was 
stronger among women with planned as compared to spontaneous preterm births (16). Since 
planned preterm deliveries are typically indicated in women with medical concerns, this 
finding suggests the existence of upstream risk factors of both preterm birth and later CVD 
risk.
In the present study, there were very few cases of indicated preterm deliveries, so we were 
not able to examine them separately from spontaneous preterm births. We were, however, 
able to gain insight on etiological pathways underlying the relation of preterm delivery with 
postpartum SBP by accounting for blood pressure during the first trimester (Model 2) and 
hypertensive complications that transpired later in pregnancy (Model 3). Counter to our 
expectations, accounting for first semester SBP did not attenuate the estimate (3.81 [0.58, 
7.04] mmHg vs. 3.99 [CI: 0.82, 7.16] mmHg before vs. after adjustment for first trimester 
SBP and gestational age-at-blood-draw). However, in corroboration with findings from 
Fraser et al. (10), accounting for hypertensive disorders during pregnancy attenuated the 
estimate towards the null, suggesting that a substantial portion of the relation between 
preterm birth and higher postpartum SBP is marked by hypertension during mid-to-late 
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pregnancy. This could be due to the fact that hypertension is a risk factor for preterm birth 
that may also cause permanent damage to endothelial vasculature, ultimately leading to 
long-term alterations in arterial pressure (24). We observed similar trends among women 
with no history of hypertension and no diagnosis of chronic hypertension during pregnancy 
(Model 2: 3.27 [0.09, 6.44] mmHg), highlighting the importance of monitoring the 
progression of cardiovascular risk factors among normotensive women with a history of 
preterm delivery.
We also found an inverse relation of preterm birth with postpartum HDL levels that 
remained robust to covariate adjustment. While we cannot discount the possibility that this 
association could be a reflection of adverse lipid profiles prior to or during pregnancy (25, 
26), it is a salient finding considering that low HDL is a strong predictor of CVD risk (27–
29), irrespective of other lipid components (28). Interestingly, in the WISH study, preterm 
birth predicted alterations in total cholesterol, LDL, and triglycerides, but not HDL. The 
discrepancy could be due to differences in population composition, and thus different 
predisposing factors for preterm birth as well as CVD. Additionally, the participants in 
WISH exhibited a worse cardiovascular risk profile than women in the present study, and it 
is possible that reductions in HDL precede elevations in the other lipid components. Future 
studies examining associations of preterm birth with lipid fractions over a longer duration of 
follow-up are warranted in other populations.
In addition to our main findings, there were two other noteworthy trends. First, we observed 
a direct association between preterm birth and insulin resistance at 3 years postpartum after 
accounting for age and race/ethnicity. Although the association became attenuated after 
covariate adjustment, this may have been an artifact of the small sample size of women who 
provided fasting blood. Because insulin resistance is part of the cluster of inflammation-
mediated metabolic perturbations that could transpire through endothelial dysfunction (30), 
future studies should assess this association in a larger population of women. It is also worth 
mentioning that preterm birth did not predict BMI, weight change, or waist circumference 
by 3 or 7 years postpartum, indicating that the associations with metabolic sequelae were not 
mediated by changes in maternal adiposity.
This study has some limitations. First, there is the possibility of selection bias since we 
restricted the analysis to women without intervening pregnancies, who may be inherently 
different from their counterparts; thus limiting generalizability. Second, there could be self-
report bias of pre-pregnancy weight. However, we conducted a validation study comparing 
self-reported pre-pregnancy weight with clinically-measured weight in the medical records 
within 3 months before the last menstrual period; correlation between self-reported and 
objectively-measured BMI was high (r=0.99), and mean underreporting of weight (~1 kg) 
did not differ by race/ethnicity, gestational age at study enrollment, or weight itself (31); 
thus, the degree of self-report bias likely had minimal effect on the results. Third, due to the 
small number of preterm births and because we did not require fasting biospecimens, we 
may have been underpowered to detect smaller associations for some of the biomarkers. We 
hope to improve participation in blood draws for future studies and request that women fast 
prior to the visit. Third, we did not have data on use of statins or anti-hypertensive 
medications, which could influence some of the postpartum outcomes, although excluding 
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women with a history of diagnosed hypertension did not alter findings. Fourth, because 
Project Viva participants are predominantly white, relatively well-educated, and all resided 
in one region of the U.S., the results may not be generalizable to other populations. Finally, 
we cannot discount the possibility of chance findings.
In conclusion, delivery of a preterm infant was associated with higher SBP and lower HDL 
at 3 years postpartum. Although the magnitudes of associations are modest, they are 
comparable to subclinical differences detected in young adults (32) and may have important 
implications for longer term cardiovascular risk. For example, considering that a10 mmHg 
increment in SBP was associated with 1.5 to 2.5 times greater risk of CVD over 10 years of 
follow-up among middle-aged women in the Framingham cohort (33), the ~4 mmHg 
difference we observed between women with vs. without a preterm birth may have 
implications for long term cardiovascular health. Our findings suggest that excess CVD risk 
is detectable among reproductive-aged women with a history of preterm birth before 
establishment of overt clinical disease. Possible avenues for CVD prevention include more 
frequent lipid and blood pressure screening, and earlier behavioral interventions (e.g. diet 
and lifestyle modifications) (34), both of which have been previously shown to improve 
CVD risk parameters (34).
Acknowledgments
This work was funded by NIH grants R21 DK053539, R37 HD 034567, R01 HL 064925, and R01 HL 075504. Dr. 
Oken was supported by K24 HD069408, P30 DK092924. Dr. Perng was supported by the Thomas O’Pyle 
fellowship at the Harvard Pilgrim Health Care Institute.
We are indebted to the mothers and children of Project Viva for their generous participation, and appreciate the 
invaluable assistance of past and present Project Viva staff.
Abbreviations
BMI body mass index
GWG gestational weight gain
CRP C-reactive protein
DBP diastolic blood pressure
IL-6 interleukin-6
HDL high density lipoprotein
LDL low density lipoprotein
SBP systolic blood pressure
References
1. Center for Disease Control and Prevention. Preterm Birth. [cited 2014 February 19]. Available from: 
http://www.cdc.gov/reproductivehealth/maternalinfanthealth/PretermBirth.htm.
2. Hastie CE, Smith GC, Mackay DF, Pell JP. Maternal risk of ischaemic heart disease following 
elective and spontaneous pre-term delivery: retrospective cohort study of 750 350 singleton 
pregnancies. Int J Epidemiol. 2011; 40(4):914–9. [PubMed: 21278195] 
Perng et al. Page 9













3. Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular 
events: a retrospective cohort study of 119,668 births. Am J Epidemiol. 2004; 159(4):336–42. 
[PubMed: 14769636] 
4. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: 
a retrospective cohort study of 129,290 births. Lancet. 2001; 357(9273):2002–6. [PubMed: 
11438131] 
5. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA. Early or recurrent preterm birth and 
maternal cardiovascular disease risk. Ann Epidemiol. 2010; 20(8):604–9. [PubMed: 20609340] 
6. Kessous R, Shoham-Vardi I, Pariente G, Holcberg G, Sheiner E. An association between preterm 
delivery and long-term maternal cardiovascular morbidity. Am J Obstet Gynecol. 2013; 209(4):368, 
e1–8. [PubMed: 23800639] 
7. Bonamy AK, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth characteristics and 
subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. 
Circulation. 2011; 124(25):2839–46. [PubMed: 22124377] 
8. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-
eclampsia: population based cohort study. BMJ. 2001; 323(7323):1213–7. [PubMed: 11719411] 
9. Skjaerven R, Wilcox AJ, Klungsoyr K, Irgens LM, Vikse BE, Vatten LJ, et al. Cardiovascular 
mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. 
BMJ. 2012; 345:e7677. [PubMed: 23186909] 
10. Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, et al. Associations of 
pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk 
factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012; 
125(11):1367–80. [PubMed: 22344039] 
11. Mangos GJ, Spaan JJ, Pirabhahar S, Brown MA. Markers of cardiovascular disease risk after 
hypertension in pregnancy. J Hypertens. 2012; 30(2):351–8. [PubMed: 22179081] 
12. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and 
subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009; 114(5):961–70. 
[PubMed: 20168095] 
13. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin 
resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003; 133(5 
Suppl 2):1674s–83s. [PubMed: 12730484] 
14. Stuebe AM, Mantzoros C, Kleinman K, Gillman MW, Rifas-Shiman S, Seely EW, et al. 
Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum. Obstet 
Gynecol. 2011; 118(5):1065–73. [PubMed: 22015874] 
15. Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G. Previous 
gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. 2012; 
2012:458610. [PubMed: 22518122] 
16. Catov JM, Dodge R, Barinas-Mitchell E, Sutton-Tyrrell K, Yamal JM, Piller LB, et al. Prior 
preterm birth and maternal subclinical cardiovascular disease 4 to 12 years after pregnancy. J 
Womens Health. 2013; 22(10):835–43.
17. Oken E, Baccarelli A, Gold D, Kleinman K, Litonjua A, De Meo E. Cohort profile: Project Viva. 
Int J Epidemiol. In Press. 
18. Regnault N, Gillman MW, Rifas-Shiman SL, Eggleston E, Oken E. Sex-specific associations of 
gestational glucose tolerance with childhood body composition. Diabetes Care. 2013; 36(10):
3045–53. [PubMed: 23877978] 
19. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth 
weight for gestational age using a United States national reference. BMC Pediatr. 2003; 3:6. 
[PubMed: 12848901] 
20. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, et al. Relationship of blood 
pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes 
in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern 
Med. 2001; 161(12):1501–8. [PubMed: 11427097] 
Perng et al. Page 10













21. Heinemann M, Sellick K, Rickard C, Reynolds P, McGrail M. Automated versus manual blood 
pressure measurement: a randomized crossover trial. Int J Nurs Pract. 2008; 14(4):296–302. 
[PubMed: 18715391] 
22. Sattar N. Do pregnancy complications and CVD share common antecedents? Atheroscler Suppl. 
2004; 5(2):3–7. [PubMed: 15121029] 
23. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later 
cardiovascular risk: common antecedents? Circulation. 2010; 122(6):579–84. [PubMed: 
20660802] 
24. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of 
hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J 
Physiol. 2008; 294(2):H541–50.
25. Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, et al. Early pregnancy lipid 
concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007; 197(6):610, e1–7. 
[PubMed: 18060950] 
26. Catov JM, Ness RB, Wellons MF, Jacobs DR, Roberts JM, Gunderson EP. Prepregnancy lipids 
related to preterm birth risk: the coronary artery risk development in young adults study. J Clin 
Endocrinol Metab. 2010; 95(8):3711–8. [PubMed: 20501685] 
27. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, et al. Major lipids, 
apolipoproteins, and risk of vascular disease. JAMA. 2009; 302(18):1993–2000. [PubMed: 
19903920] 
28. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a 
protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977; 62(5):
707–14. [PubMed: 193398] 
29. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The 
Framingham Heart Study. Arteriosclerosis. 1988; 8(6):737–41. [PubMed: 3196218] 
30. Hsueh WA, Quinones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 
2003; 92(4a):10j–7j.
31. Oken E, Taveras EM, Kleinman KP, Rich-Edwards JW, Gillman MW. Gestational weight gain and 
child adiposity at age 3 years. Am J Obstet Gynecol. 2007; 196(4):322. e1–8. [PubMed: 
17403405] 
32. Kestila P, Magnussen CG, Viikari JS, Kahonen M, Hutri-Kahonen N, Taittonen L, et al. 
Socioeconomic status, cardiovascular risk factors, and subclinical atherosclerosis in young adults: 
the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2012; 32(3):815–
21. [PubMed: 22223734] 
33. Kannel WB, Vasan RS, Levy D. Is the relation of systolic blood pressure to risk of cardiovascular 
disease continuous and graded, or are there critical values? Hypertension. 2003; 42(4):453–6. 
[PubMed: 12975387] 
34. Robbins CL, Dietz PM, Bombard J, Tregear M, Schmidt SM, Tregear SJ. Lifestyle interventions 
for hypertension and dyslipidemia among women of reproductive age. Prev Chron Dis. 2011; 
8(6):A123.
Perng et al. Page 11

























Perng et al. Page 12
Table 1
Occurrence of preterm birth (gestational age <37 vs. ≥37 weeks)
Preterm birth
Na % (n) Pb
Overall 805 6.7 (54)
Maternal & family characteristics
Age at enrollment 0.5 0
 15–24 years 65 6.2 (4)
 25–34 years 407 7.6 (31)
 35–44 years 333 5.7 (19)
Race/ethnicity 0.0 01
 Black 14 1 7.8 (11)
 Hispanic 64 14.1 (9)
 White 523 4.6 (24)
 Asian 40 20.0 (8)
 Other 35 5.7 (2)
Marital status 0.0 7
 Married/cohabiting 72 8 6.2 (45)
 Single 77 11.7 (9)
Annual household income 0.6 6
 < $20,000 3 3 6.1 (2)
 $20,000 – $39,999 96 7.3 (7)
 $40,000 – $69,999 171 4.1 (7)
 > $70,000 434 7.1 (31)
Education 0.0 1
 Primary 76 10.5 (8)
 Secondary 484 7.9 (38)
 University 245 3.3 (8)
Smoking habits 0.4 5
 Never 56 0 7.3 (41)
 Quit before pregnancy 157 4.5 (7)
 Smoked in early pregnancy 86 7.0 (6)
Partner’s BMI 0.7 6
 Not overweight (<25 kg/m2) 27 3 7.0 (19)
 Overweight (≥25 kg/m2) 500 6.4 (32)
Perinatal characteristics
Parity 0.6 7
 0 24 3 7.4 (18)
 1 360 6.4 (23)
 ≥2 202 6.4 (13)
Pre-pregnancy BMI 0.4 0
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Preterm birth
Na % (n) Pb
 Underweight (<18.5 kg/m2) 2 7 0.0 (0)
 Normal (18.5–24.9 kg/m2) 415 6.5 (29)
 Overweight (25.0–29.9 kg/m2) 177 7.8 (15)
 Obese (≥30.0 kg/m2) 432 7.0 (10)
Pre-pregnancy hypertensive history 0.80
 Yes 3 9 7.7 (3)
 No 707 6.7 (47)
Gestational glucose tolerance 0.23
 Normoglycemic 65 4 6.0 (39)
 Isolated hyperglycemia 79 5.1 (4)
 Impaired glucose tolerance 31 9.7 (3)
 Gestational diabetes 37 10.8 (4)
Hypertensive disorders of pregnancy 0.0 01
 Normal 72 1 5.7 (41)
 Chronic hypertension 15 20.0 (3)
 Gestational hypertension 45 8.9 (4)
 Preeclampsia 24 25.0 (6)
Mode of delivery 0.06
 Vaginal 62 1 5.8 (36)
 C-section 183 9.8 (18)
Childs sex 0.1 1
 Male 40 7 8.1 (33)
 Female 398 5.3 (21)
Fetal growth 0.0 02
 SGA (<10th %ile) 4 0 15.0 (6)
 AGA (10 – ≤90th %ile) 643 7.2 (46)
 LGA (>90th %ile) 121 1.7 (2)
Prudent dietary pattern during 1st trimester 0.1 9
 Q1 (least similar) 181 8.8 (16)
 Q2 182 6.6 (12)
 Q3 181 7.2 (13)
 Q4 (most similar) 182 5.0 (9)
Western dietary pattern during 1st trimester 0.51
 Q1 (least similar) 182 8.8 (16)
 Q2 181 6.1 (11)
 Q3 181 5.5 (10)
 Q4 (most similar) 182 7.1 (13)
Pre-pregnancy physical activity 0.32
 Q1 (lowest) 15 1 12.6 (19)
 Q2 149 2.0 (3)
 Q3 204 5.9 (12)
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Preterm birth
Na % (n) Pb
 Q4 (highest) 173 8.1 (14)
a
Total may be < 805 due to missing values.
b
Represents a test for linear trend in which the ordinal predictor is entered into the model as a continuous variable, except for race/ethnicity, 
smoking habits, partner’s BMI, pre-pregnancy hypertensive history, hypertensive disorders of pregnancy, and delivery method (Wald test).
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